Cullinan Therapeutics (CGEM) News Today $6.53 -0.09 (-1.36%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$6.52 -0.01 (-0.15%) As of 09/12/2025 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CGEM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Cullinan Therapeutics (NASDAQ:CGEM) Given "Buy" Rating at HC WainwrightSeptember 14 at 8:14 AM | marketbeat.comBTIG Research Reiterates Buy Rating for Cullinan Therapeutics (NASDAQ:CGEM)September 13 at 8:23 AM | marketbeat.comCullinan Therapeutics to Participate in Fireside Chat at the Stifel 2025 Virtual Immunology and Inflammation ForumSeptember 12 at 7:00 AM | globenewswire.comCullinan Therapeutics (NASDAQ:CGEM) Earns Buy Rating from BTIG ResearchSeptember 12 at 2:05 AM | americanbankingnews.comCullinan Therapeutics, Inc. (CGEM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 10, 2025 | seekingalpha.comTrexquant Investment LP Invests $518,000 in Cullinan Therapeutics, Inc. $CGEMSeptember 10, 2025 | marketbeat.comTaiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib at the IASLC 2025 World Conference on Lung CancerSeptember 9, 2025 | prnewswire.comWalleye Capital LLC Decreases Stake in Cullinan Therapeutics, Inc. $CGEMSeptember 8, 2025 | marketbeat.comRafferty Asset Management LLC Sells 34,716 Shares of Cullinan Therapeutics, Inc. $CGEMSeptember 5, 2025 | marketbeat.comBraidwell LP Reduces Position in Cullinan Therapeutics, Inc. $CGEMSeptember 3, 2025 | marketbeat.com188,030 Shares in Cullinan Therapeutics, Inc. $CGEM Bought by Nuveen LLCSeptember 2, 2025 | marketbeat.comCullinan Therapeutics, Inc. $CGEM Holdings Raised by Vanguard Group Inc.August 31, 2025 | marketbeat.comCullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Average Rating of "Buy" by AnalystsAugust 30, 2025 | marketbeat.comBrokers Set Expectations for CGEM Q3 EarningsAugust 26, 2025 | marketbeat.comResearch Analysts Offer Predictions for CGEM Q1 EarningsAugust 24, 2025 | marketbeat.comCullinan Therapeutics, Inc. $CGEM Shares Acquired by Algert Global LLCAugust 24, 2025 | marketbeat.comHC Wainwright Reiterates Buy Rating for Cullinan Therapeutics (NASDAQ:CGEM)August 23, 2025 | marketbeat.comCullinan Therapeutics to Participate in Upcoming Investor ConferencesAugust 21, 2025 | globenewswire.comCullinan Therapeutics assumed with a Buy at H.C. WainwrightAugust 21, 2025 | msn.comVoss Capital LP Acquires 52,639 Shares of Cullinan Therapeutics, Inc. $CGEMAugust 21, 2025 | marketbeat.comMorgan Stanley Has Lowered Expectations for Cullinan Therapeutics (NASDAQ:CGEM) Stock PriceAugust 20, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Raises Stock Holdings in Cullinan Therapeutics, Inc. $CGEMAugust 20, 2025 | marketbeat.comWilliam Blair Has Pessimistic Outlook of CGEM Q3 EarningsAugust 11, 2025 | marketbeat.comCullinan Therapeutics: Q2 Earnings SnapshotAugust 7, 2025 | finance.yahoo.comCullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial ResultsAugust 7, 2025 | globenewswire.comCullinan Therapeutics (CGEM) to Release Earnings on ThursdayAugust 7, 2025 | marketbeat.comCullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Consensus Rating of "Buy" by BrokeragesAugust 3, 2025 | marketbeat.comCullinan Therapeutics to Present Updated Zipalertinib Data at IASLC 2025 World Conference on Lung CancerAugust 1, 2025 | msn.comCullinan Therapeutics: Betting On Zipalertinib NDA CatalystJuly 15, 2025 | seekingalpha.comWe're Keeping An Eye On Cullinan Therapeutics' (NASDAQ:CGEM) Cash Burn RateJuly 10, 2025 | finance.yahoo.comCullinan Therapeutics, Inc. (NASDAQ:CGEM) Receives Consensus Recommendation of "Buy" from BrokeragesJuly 9, 2025 | marketbeat.comCGEM - Cullinan Therapeutics Inc Dividends - MorningstarJuly 2, 2025 | morningstar.comMAssenagon Asset Management S.A. Cuts Stock Position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM)June 21, 2025 | marketbeat.comCullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Average Rating of "Buy" by BrokeragesJune 14, 2025 | marketbeat.comCullinan Therapeutics (NASDAQ:CGEM) Coverage Initiated at Stifel NicolausJune 11, 2025 | marketbeat.comCullinan Therapeutics (NASDAQ:CGEM) Shares Down 4.7% - Time to Sell?June 5, 2025 | marketbeat.comCullinan Therapeutics Nabs Licensing Rights to Myeloma TreatmentJune 4, 2025 | marketwatch.comCullinan Therapeutics in-pact with Genrix Bio for velinotamigJune 4, 2025 | msn.comCullinan Therapeutics Licenses Rights to Velinotamig, a Clinical-Stage BCMA-Directed Bispecific T Cell Engager, from Genrix Bio for Development in Autoimmune DiseasesJune 4, 2025 | globenewswire.comBank of America Corp DE Cuts Position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM)June 4, 2025 | marketbeat.comCullinan Therapeutics, Inc. (NASDAQ:CGEM) Sees Significant Decline in Short InterestJune 2, 2025 | marketbeat.comTaiho Oncology and Cullinan Therapeutics Announce Pivotal REZILIENT1 Phase 1/2 Data Published in the Journal of Clinical OncologyJune 1, 2025 | prnewswire.comCullinan Therapeutics (NASDAQ:CGEM) Stock Price Up 9.2% - Here's WhyMay 30, 2025 | marketbeat.comCullinan Therapeutics to Host Analyst and Investor Event at 2025 ASCO Annual Meeting and Participate in Jefferies 2025 Global Healthcare ConferenceMay 29, 2025 | globenewswire.comWoodline Partners LP Makes New $2.04 Million Investment in Cullinan Therapeutics, Inc. (NASDAQ:CGEM)May 27, 2025 | marketbeat.comCullinan Therapeutics, Inc. (NASDAQ:CGEM) Shares Acquired by Millennium Management LLCMay 26, 2025 | marketbeat.comAmeriprise Financial Inc. Raises Stake in Cullinan Therapeutics, Inc. (NASDAQ:CGEM)May 26, 2025 | marketbeat.comCullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial of Zipalertinib at ASCO 2025May 22, 2025 | globenewswire.com115,000 Shares in Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Acquired by BNP Paribas Financial MarketsMay 22, 2025 | marketbeat.comPatient Square Capital LP Has $10.71 Million Holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM)May 16, 2025 | marketbeat.com Get Cullinan Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CGEM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CGEM Media Mentions By Week CGEM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CGEM News Sentiment▼0.710.93▲Average Medical News Sentiment CGEM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CGEM Articles This Week▼114▲CGEM Articles Average Week Get the Latest News and Ratings for CGEM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Cullinan Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies EWTX News AUPH News CDTX News PAHC News ARDX News TWST News VERA News AVDL News COGT News SNDX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CGEM) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cullinan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cullinan Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CGEM Stock Alerts